Epilepsy Monitoring Devices Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 510.03 Million |
| Market Size (2029) | USD 661.87 Million |
| CAGR (2024 - 2029) | 5.35 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Epilepsy Monitoring Devices Market Analysis
The Global Epilepsy Monitoring Devices Market size is estimated at USD 510.03 million in 2024, and is expected to reach USD 661.87 million by 2029, growing at a CAGR of 5.35% during the forecast period (2024-2029).
COVID-19 is expected to have a positive impact on the global demand for epilepsy monitoring devices in its latter phase since the population with epilepsy was at a higher risk of encountering fatalities. This is mainly due to the increasing incidences of seizures and epilepsy among the people who were affected by COVID-19 disease. According to the data published by the American Epilepsy Society (AES) in December 2021, patients with epilepsy were nearly 1.5 times more likely to die of COVID-19 than other infected patients. These circumstances have increased the demand for epilepsy monitoring devices to opt for treatments early on. Thus, COVID-19 is expected to have a considerable impact on the growth of the market.
Increasing incidences of epilepsy among people across the world are expected to drive the growth of the epilepsy monitoring devices market. According to the World Health Organization's February 2022 update, around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. It also reported that nearly 80% of people with epilepsy live in low- and middle-income countries. The same source also reported that it is estimated that up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated. Therefore, the increasing incidences of epilepsy cases across the globe are expected to increase the demand for epilepsy monitoring devices as they provide critical insights into the type of seizures. Furthermore, the increase in the geriatric population vulnerable to developing epilepsy and seizures across the globe also plays a crucial role in driving the market's growth.
Additionally, the investment by the market players and advancements in technology are also propelling the growth of the market. For instance, in July 2022, Breakthrough Victoria invested in Victorian medical technology group Seer Medical to support its plan to become one of the global leaders in epilepsy home monitoring and management. The contribution will allow Seer to nearly double its workforce and footprint in Victoria while expanding into the United States and the United Kingdom.
Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period. However, the high cost of equipment and unfavorable reimbursement policies may hinder the growth of the market.
Epilepsy Monitoring Devices Market Trends
This section covers the major market trends shaping the Epilepsy Monitoring Devices Market according to our research experts:
The Conventional Devices Segment is Expected to Hold a Major Market Share Over the Forecast Period
The conventional devices segment is expected to hold a significant share in the market owing to its safety and efficiency. Conventional devices refer to electroencephalogram (EEG) devices used for the continuous monitoring of patients.
Amid COVID-19, the demand for epilepsy monitoring devices was increasing as there was a higher prevalence of epilepsy among infected patients. For instance, according to the study titled "Epilepsy during the COVID19 pandemic lockdown: a US population survey" published in June 2021, 25% of people in the United States reported an increase in seizure cases during the pandemic period. Hence, such incidents boosted the demand for conventional devices for epilepsy monitoring during COVID-19 owing to their popularity and adoption within the patient population.
Additionally, conventional devices are widely used in hospitals and clinics for continuous monitoring purposes. Conventional devices provide a proper diagnosis to professionals about the type of seizure to prescribe the appropriate treatment. These factors can be attributed to the increasing demand for continuous, non-invasive monitoring of epilepsy.
Furthermore, in December 2021, iMediSync showcased its comprehensive EEG solution (hardware + software + remote telehealth solution) iSyncWave to perform brain mental health screening and predictive analysis of potential mental conditions in just 10 minutes. The presence of such advanced products in the market also contributes to the growth of the segment.
Thus, owing to the abovementioned factors, the market segment is expected to project growth over the forecast period.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period
The high incidences of neurological disorders, especially epilepsy, and a large number of end-users in the United States are the major factors for the growth of epilepsy monitoring devices in this region.
According to the article titled "Epidemiology of status epilepticus in the United States: A systematic review" published in November 2020, the incidence of all status epilepticus in patients of all ages in the United States ranged from 18.3 to 41 per 100,000 people per year. Such a high burden of epilepsy has contributed to the increase in the demand for epilepsy monitoring devices to provide proper treatment to patients.
Furthermore, the presence of the major market players in this region and their spending extensively on research and development of new products is also expected to boost the growth of the market in this region. For instance, in January 2021, BioSerenity received 510(k) clearance for its electroencephalography (EEG) wearable device system from the United States Food and Drug Administration (FDA). This clearance includes BioSerenity's NeuronauteEEG system and IceCap EEG wearable device, which are intended to allow physicians to remotely monitor and assess the electrical brain activity of people living with epilepsy.
Thus, owing to the abovementioned factors, the studied market is expected to show growth in the North American region.
Epilepsy Monitoring Devices Industry Overview
The Epilepsy Monitoring Devices market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some companies currently dominating the market are Medpage Ltd, Boston Scientific Corporation, Cadwell Industries, Compumedics USA inc., Emfit Corporation, Empatica Inc., General Electric company, Koninklijke Philips N.V., Masimo, Neurosoft, Neurowave systems, Nihon Kohden Corporation, Nonin, and others.
Epilepsy Monitoring Devices Market Leaders
-
Medpage Ltd
-
Koninklijke Philips N.V.
-
Boston Scientific Corporation
-
Cadwell Industries
-
Emfit Corporation
*Disclaimer: Major Players sorted in no particular order
Epilepsy Monitoring Devices Market News
- In May 2022, Spanish start-up mjn-NEURO launched the mjn-SERAS that helps in seizure detection in the United Kingdom. It is a revolutionary device that uses artificial intelligence to predict seizures with up to 3 minutes of advanced warning.
- In February 2022, Epitel, maker of a wearable electroencephalogram (EEG) system, raised USD 12.5 million for seizure detection in Series A funding.
Epilepsy Monitoring Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing incidence of Epilepsy
- 4.2.2 Rising awareness of neurodegenerative disorders, including epilepsy
-
4.3 Market Restraints
- 4.3.1 High cost of the equipment
- 4.3.2 Unfavourable Reimbursement policies
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - in USD million)
-
5.1 By Product
- 5.1.1 Conventional devices
- 5.1.2 Wearable devices
-
5.2 By Technology
- 5.2.1 Vagus nerve stimulation
- 5.2.2 Deep brain stimulation
- 5.2.3 Accelometry
- 5.2.4 Responsive neurostimulation
-
5.3 By Detection
- 5.3.1 Elecetroencephalogram
- 5.3.2 Intracranial EEG
- 5.3.3 Surface Electromyography
- 5.3.4 Video Detection Systems
-
5.4 By End User
- 5.4.1 Hospitals and Ambulatory services
- 5.4.2 Neurology centers
- 5.4.3 Diagnostic centers
-
5.5 Geography
- 5.5.1 North America
- 5.5.1.1 United States
- 5.5.1.2 Canada
- 5.5.1.3 Mexico
- 5.5.2 Europe
- 5.5.2.1 Germany
- 5.5.2.2 United Kingdom
- 5.5.2.3 France
- 5.5.2.4 Italy
- 5.5.2.5 Spain
- 5.5.2.6 Rest of Europe
- 5.5.3 Asia-Pacific
- 5.5.3.1 China
- 5.5.3.2 Japan
- 5.5.3.3 India
- 5.5.3.4 Australia
- 5.5.3.5 South Korea
- 5.5.3.6 Rest of Asia-Pacific
- 5.5.4 Middle East and Africa
- 5.5.4.1 GCC
- 5.5.4.2 South Africa
- 5.5.4.3 Rest of Middle East and Africa
- 5.5.5 South America
- 5.5.5.1 Brazil
- 5.5.5.2 Argentina
- 5.5.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Medpage Ltd
- 6.1.2 Boston Scientific Corporation
- 6.1.3 Cadwell industries
- 6.1.4 Compumedics USA inc
- 6.1.5 Emfit Corporation
- 6.1.6 Empatica Inc
- 6.1.7 General Electric company
- 6.1.8 Kninklijke Philips N.V.
- 6.1.9 Masimo
- 6.1.10 Neurosoft
- 6.1.11 Neurowave systems
- 6.1.12 Nihon Kohden Corporation
- 6.1.13 Nonin
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Epilepsy Monitoring Devices Industry Segmentation
As per the scope of this report, an epilepsy monitoring device is a type of electronic device that can identify seizures in epilepsy conditions. The Epilepsy Monitoring Devices market is segmented by Product (Conventional Devices and Wearable Devices), Technology (Vagus Nerve stimulation, Deep brain Stimulation, Accelorometry, Responsive neurostimulation), Detection devices (Electroencephalogram, Intracranial EEG, Surface Electromyography, Video Detection systems), End User (Hospitals and Ambulatory services, Neurology centers, Diagnostic centers) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values in USD million for the above segments.
| By Product | Conventional devices | |
| Wearable devices | ||
| By Technology | Vagus nerve stimulation | |
| Deep brain stimulation | ||
| Accelometry | ||
| Responsive neurostimulation | ||
| By Detection | Elecetroencephalogram | |
| Intracranial EEG | ||
| Surface Electromyography | ||
| Video Detection Systems | ||
| By End User | Hospitals and Ambulatory services | |
| Neurology centers | ||
| Diagnostic centers | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Epilepsy Monitoring Devices Market Research FAQs
How big is the Global Epilepsy Monitoring Devices Market?
The Global Epilepsy Monitoring Devices Market size is expected to reach USD 510.03 million in 2024 and grow at a CAGR of 5.35% to reach USD 661.87 million by 2029.
What is the current Global Epilepsy Monitoring Devices Market size?
In 2024, the Global Epilepsy Monitoring Devices Market size is expected to reach USD 510.03 million.
Who are the key players in Global Epilepsy Monitoring Devices Market?
Medpage Ltd, Koninklijke Philips N.V., Boston Scientific Corporation, Cadwell Industries and Emfit Corporation are the major companies operating in the Global Epilepsy Monitoring Devices Market.
Which is the fastest growing region in Global Epilepsy Monitoring Devices Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Epilepsy Monitoring Devices Market?
In 2024, the North America accounts for the largest market share in Global Epilepsy Monitoring Devices Market.
What years does this Global Epilepsy Monitoring Devices Market cover, and what was the market size in 2023?
In 2023, the Global Epilepsy Monitoring Devices Market size was estimated at USD 484.13 million. The report covers the Global Epilepsy Monitoring Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Epilepsy Monitoring Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Global Epilepsy Monitoring Devices Industry Report
Statistics for the 2024 Global Epilepsy Monitoring Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Epilepsy Monitoring Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
